# Safety and Efficacy of AST-120 in Mild to Moderate Crohn's Patients With Fistulas

> **NCT00321412** · PHASE3 · COMPLETED · sponsor: **Ocera Therapeutics** · enrollment: 191 (actual)

## Conditions studied

- Inflammatory Bowel Disease
- Intestinal Fistula

## Interventions

- **DRUG:** AST-120

## Key facts

- **NCT ID:** NCT00321412
- **Lead sponsor:** Ocera Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2008-03
- **Final completion:** 2008-09
- **Target enrollment:** 191 (ACTUAL)
- **Last updated:** 2014-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00321412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00321412, "Safety and Efficacy of AST-120 in Mild to Moderate Crohn's Patients With Fistulas". Retrieved via AI Analytics 2026-08-20 from https://api.ai-analytics.org/clinical/NCT00321412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*